Journey from Engineering E. coli to Producing Biologic Therapies

This chapter follows the guest's path from studying biochemistry and being inspired by the application of engineering principles to biology. It encompasses the speaker's venture into engineering E. coli for producing antibodies like mammalian cells, leading to cost-effective and time-efficient production of biologics. The chapter touches on the challenges faced during the Great Recession, cold-emailing pharmaceutical companies for partnerships, and the importance of finding supportive investors for growing a biotech company.